ARCHIVES

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

This article is from The Cancer Letter archive.

Vol. 17 No. 28 | July 12, 1991

Download PDF Visit The Full Archive

Related Articles

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

June 2, 2006

In Brief: Panel Appointments On President’s Desk; Breast Cancer Treatment Workshop Planned

September 14, 1979

In Brief: GAO Probe Of Cancer Control Program Nears End; Renewal Bill Mark Up Not Before Oct. 22

October 12, 1979

Evidence Links Anemia Drugs With Leukemic Transformation

December 28, 2007

In Brief: PCORI Forms Clinical Trials Advisory Board

April 4, 2014

National Action Plan Issues RFA For Grant Supplements

April 21, 1995